Laura Shawver is of Silverback Therapeutics, Inc.. Currently has a direct ownership of 210,346 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Sep 01, 2023, when has been sold 100,000 shares (Common Stock) at a price of $7.71 per share, resulting in proceeds of $771,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 210K
0% 3M change
0% 12M change
Total Value Held $0

Laura Shawver Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 01 2023
SELL
Open market or private sale
$771,000 $7.71 p/Share
100,000 Reduced 32.22%
210,346 Common Stock
Sep 01 2023
BUY
Exercise of conversion of derivative security
$127,000 $1.27 p/Share
100,000 Added 24.37%
310,346 Common Stock
Aug 04 2023
SELL
Open market or private sale
$133,412 $7.06 p/Share
18,897 Reduced 8.24%
210,346 Common Stock
Aug 04 2023
BUY
Exercise of conversion of derivative security
$23,999 $1.27 p/Share
18,897 Added 7.62%
229,243 Common Stock
Aug 03 2023
SELL
Open market or private sale
$183,010 $7.01 p/Share
26,107 Reduced 11.04%
210,346 Common Stock
Aug 03 2023
BUY
Exercise of conversion of derivative security
$33,155 $1.27 p/Share
26,107 Added 9.94%
236,453 Common Stock
Aug 02 2023
SELL
Open market or private sale
$257,232 $7.09 p/Share
36,281 Reduced 14.71%
210,346 Common Stock
Aug 02 2023
BUY
Exercise of conversion of derivative security
$46,076 $1.27 p/Share
36,281 Added 12.82%
246,627 Common Stock
Aug 01 2023
SELL
Open market or private sale
$134,560 $7.19 p/Share
18,715 Reduced 8.17%
210,346 Common Stock
Aug 01 2023
BUY
Exercise of conversion of derivative security
$23,768 $1.27 p/Share
18,715 Added 7.55%
229,061 Common Stock
Jul 07 2023
SELL
Open market or private sale
$56,336 $6.36 p/Share
8,858 Reduced 4.04%
210,346 Common Stock
Jul 07 2023
BUY
Exercise of conversion of derivative security
$11,249 $1.27 p/Share
8,858 Added 3.88%
219,204 Common Stock
Jul 06 2023
SELL
Open market or private sale
$212,453 $6.34 p/Share
33,510 Reduced 13.74%
210,346 Common Stock
Jul 06 2023
BUY
Exercise of conversion of derivative security
$42,557 $1.27 p/Share
33,510 Added 12.08%
243,856 Common Stock
Jul 05 2023
SELL
Open market or private sale
$199,427 $6.41 p/Share
31,112 Reduced 12.89%
210,346 Common Stock
Jul 05 2023
BUY
Exercise of conversion of derivative security
$39,512 $1.27 p/Share
31,112 Added 11.41%
241,458 Common Stock
Jul 03 2023
SELL
Open market or private sale
$178,214 $6.72 p/Share
26,520 Reduced 11.2%
210,346 Common Stock
Jul 03 2023
BUY
Exercise of conversion of derivative security
$33,680 $1.27 p/Share
26,520 Added 10.07%
236,866 Common Stock
Jun 02 2023
SELL
Open market or private sale
$187,239 $6.95 p/Share
26,941 Reduced 11.35%
210,346 Common Stock
Jun 02 2023
BUY
Exercise of conversion of derivative security
$34,215 $1.27 p/Share
26,941 Added 10.2%
237,287 Common Stock
Jun 01 2023
SELL
Open market or private sale
$496,801 $6.8 p/Share
73,059 Reduced 25.78%
210,346 Common Stock
Jun 01 2023
BUY
Exercise of conversion of derivative security
$92,784 $1.27 p/Share
73,059 Added 20.5%
283,405 Common Stock
May 09 2023
SELL
Open market or private sale
$227,798 $5.31 p/Share
42,900 Reduced 16.94%
210,346 Common Stock
May 09 2023
BUY
Exercise of conversion of derivative security
$54,483 $1.27 p/Share
42,900 Added 14.49%
253,246 Common Stock
May 08 2023
SELL
Open market or private sale
$351,736 $6.16 p/Share
57,100 Reduced 21.35%
210,346 Common Stock

Also insider at

RLAY
Relay Therapeutics, Inc. Healthcare
NKTX
Nkarta, Inc. Healthcare
LS

Laura Shawver

Seattle, WA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Track Activities on SBTX